Literature DB >> 3598327

Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.

H S Goh, J R Jass, W S Atkin, J Cuzick, J M Northover.   

Abstract

The DNA content of 203 cases of rectal cancer, with at least 15 years follow-up, was analysed by flow cytometry. One hundred and twenty-nine (64%) were DNA aneuploid and corrected survivals were significantly influenced by ploidy distribution (p less than 0.01). The DNA content and details of stage and grade were subjected to multivariate analysis using the Cox regression model. Ploidy was entered into models including Dukes' stage alone, tumour differentiation alone, Dukes' stage and differentiation in combination and a more comprehensive range of discrete stage- and grade-related parameters. All four models demonstrated its independent contribution to survival. However, its contribution was very small (5%, 18%, 5%, 4% respectively). These findings illustrate that results based on new technological developments should not be viewed in isolation, but their values must be assessed in combination with traditionally available data by means of multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598327     DOI: 10.1007/bf01648992

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

Review 1.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

2.  Histopathology reporting in large bowel cancer.

Authors:  W K Blenkinsopp; S Stewart-Brown; L Blesovsky; G Kearney; L P Fielding
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

3.  DNA content of murine fibrosarcoma cell lines with varying metastatic potential.

Authors:  J P McCoy; W Schade; G E Merz; T Esch; J Varani; J L Hudson
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia.

Authors:  A T Look; S L Melvin; D L Williams; G M Brodeur; G V Dahl; D K Kalwinsky; S B Murphy; A M Mauer
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

6.  An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder.

Authors:  F A Klein; H W Herr; W F Whitmore; P C Sogani; M R Melamed
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

7.  DNA content and the adenoma-carcinoma sequence in the colorectum.

Authors:  H S Goh; J R Jass
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

8.  Observer variation in the histological grading of rectal carcinoma.

Authors:  G D Thomas; M F Dixon; N C Smeeton; N S Williams
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

10.  Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma.

Authors:  T O Rognum; E Thorud; K Elgjo; P Brandtzaeg; H Orjasaeter; K Nygaard
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

View more
  13 in total

1.  Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.

Authors:  S Rowley; K M Newbold; J Gearty; M R Keighley; I A Donovan; J P Neoptolemos
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

2.  Flow cytometry in colon cancer: does flow cytometric cell cycle analysis help predict for short-term recurrence in patients with colorectal carcinoma?

Authors:  C Hixon; J Furlong; A Silbergleit
Journal:  J Natl Med Assoc       Date:  1995-11       Impact factor: 1.798

3.  Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.

Authors:  J F Hamming; L J Schelfhout; C J Cornelisse; C J van de Velde; B M Goslings; J Hermans; G J Fleuren
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 4.  Reporting colorectal cancer.

Authors:  J R Jass; B C Morson
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 5.  The prognostic value of flow cytometric DNA analysis in colorectal cancer patients.

Authors:  H Suzuki
Journal:  Jpn J Surg       Date:  1988-09

6.  Detection of ploidy in colorectal tumors. A comparison between flow cytometry and cytogenetics.

Authors:  A Laquerriere; P Peulve; M A Scotte; S X Ma; M Paresy; P Teniere; J Hemet
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

7.  Do aggressive subclones within primary colorectal cancer give rise to liver metastases?

Authors:  J R Jass; K Mukawa; P I Richman; P A Hall
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

8.  Clinical importance of DNA content in rectal cancer measured by flow cytometry.

Authors:  J R Jass; K Mukawa; H S Goh; S B Love; D Capellaro
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

9.  Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

Authors:  G Lindmark; B Glimelius; L Påhlman; P Enblad
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

10.  DNA densitometry of colorectal cancer.

Authors:  G T Deans; K Williamson; P Hamilton; M Heatley; K Arthurs; C C Patterson; B J Rowlands; T G Parks; R A Spence
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.